Company Profiles

driven by the PitchBook Platform

Arecor

Description

Provider of technology designed to prevent the degradation of proteins and vaccines during storage. The company's technology enhance the commercial value and practical utility of many types of proteins and applications, which include vaccines and therapeutic proteins, enabling healthcare providers to improve the treatment of diabetes care via the innovative reformulation of approved proteins and peptides.

2007

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$1.31M

Latest Deal Amount

$7.58M

Total Amount Raised

Description

Provider of technology designed to prevent the degradation of proteins and vaccines during storage. The company's technology enhance the commercial value and practical utility of many types of proteins and applications, which include vaccines and therapeutic proteins, enabling healthcare providers to improve the treatment of diabetes care via the innovative reformulation of approved proteins and peptides.

Website:

www.arecor.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Enterprise Systems (Healthcare)

Primary Office

Chesterford Research Park Little Chesterford CB10 1XLEngland +44 (0)12 2342 6060
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Arecor's full profile, request a free trial.

Arecor Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Arecor Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Arecor Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Biomedical CatalystOther000 0000000 0000
Cambridge Capital GroupAngel GroupMinority000 0000000 0000
DSM AppsCorporationMinority000 0000000 0000
DSM VenturingCorporate Venture CapitalMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Biomedical Catalyst Other
Cambridge Capital Group Angel Group
DSM Apps Corporation
DSM Venturing Corporate Venture Capital
Individual Investor Angel (individual)

Arecor Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Sarah Howell Ph.DChief Executive Officer & Board Member
Jan Jezek Ph.DChief Scientific Officer
David GerringHead of Development
Sarah Howell Ph.D Chief Executive Officer & Board Member
Jan Jezek Ph.D Chief Scientific Officer
David Gerring Head of Development

Arecor Board Members (7)

NameRepresentingRoleSinceContact
Info
Alan Smith Ph.DSelfBoard Member000 0000
Andrew LaneUnilever VenturesDirector000 0000
Andrew Richards Ph.DSelfBoard Member000 0000
Ian FreelanceDSM VenturingSenior Investment Manager000 0000
Sarah Howell Ph.DArecorChief Executive Officer & Board Member000 0000
Alan Smith Ph.D Board Member Self
Andrew Lane Director Unilever Ventures
Andrew Richards Ph.D Board Member Self
Ian Freelance Senior Investment Manager DSM Venturing
Sarah Howell Ph.D Chief Executive Officer & Board Member Arecor
Request full access to PitchBook